Drug
doxorubicin
1 HCP commentary report on clinical trials studying doxorubicin. Each report covers what clinicians said in public about one trial, with the source behind every view.
| Trial | Indication | Phase | Statements | HCP sources | Size | Updated | Preview |
|---|---|---|---|---|---|---|---|
| CALGB-10403 NCT00558519 · Alliance for Clinical Trials in Oncology | Leukemia | Phase 2 | 1,065 | 28 | Deep | Oct 8, 2026 | Preview |